Biocryst Pharmaceuticals (BCRX) Technical (Analysis) Reports Biocryst Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Biocryst Pharmaceuticals (BCRX)
Technical Analysis Report for USA stock BCRX Biocryst Pharmaceuticals. Dated: 27 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock BCRX Biocryst Pharmaceuticals then click here. or read Experts views on Biocryst Pharmaceuticals or Forecast & share price targets of Biocryst Pharmaceuticals
Biocryst Pharmaceuticals Opened at 7.92 and Closed at: 8.09, which is 2.6% of previous session's close. It moved within a range of 7.81 and 8.12
The session was a Bullish session with an average volume of 7090810, which is 38.22% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 7.95 and resistance for tomorrow is 8.26
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 7.89, 7.7 resistance for tomorrow's hourly charts is 8.2, 8.32
10 Day SMA for Biocryst Pharmaceuticals (BCRX) is 7.9 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Biocryst Pharmaceuticals (BCRX) is 8.07 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Biocryst Pharmaceuticals (BCRX) is 8.71 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 9.11 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Biocryst Pharmaceuticals is 8.72 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Biocryst Pharmaceuticals is at 8.07 and 200 DMA is at 8.72, while 50 DMA and 100 DMA are at 8.71 and 9.11 respectively
Biocryst Pharmaceuticals (BCRX) moving average of 20 SMA is at 8.07 and 20 EMA is at 8.1
| Date | Closing Price | 20 SMA | 20 EMA |
| 27 Tue Oct | 8.09 | 8.07 | 8.1 |
| 26 Mon Oct | 7.88 | 8.08 | 8.1 |
| 23 Fri Oct | 7.65 | 8.11 | 8.12 |
| 22 Thu Oct | 7.78 | 8.15 | 8.17 |
| 21 Wed Oct | 7.75 | 8.19 | 8.21 |
| 20 Tue Oct | 7.94 | 8.23 | 8.26 |
Biocryst Pharmaceuticals (BCRX) moving average of 50 SMA is at 8.71 and 50 EMA is at 8.51
| Date | Closing Price | 50 SMA | 50 EMA |
| 27 Tue Oct | 8.09 | 8.71 | 8.51 |
| 26 Mon Oct | 7.88 | 8.75 | 8.53 |
| 23 Fri Oct | 7.65 | 8.79 | 8.56 |
| 22 Thu Oct | 7.78 | 8.83 | 8.6 |
| 21 Wed Oct | 7.75 | 8.89 | 8.63 |
| 20 Tue Oct | 7.94 | 8.94 | 8.67 |
Biocryst Pharmaceuticals (BCRX) moving average of 100 SMA is at 9.11 and 100 EMA is at 8.79
| Date | Closing Price | 100 SMA | 100 EMA |
| 27 Tue Oct | 8.09 | 9.11 | 8.79 |
| 26 Mon Oct | 7.88 | 9.11 | 8.8 |
| 23 Fri Oct | 7.65 | 9.12 | 8.82 |
| 22 Thu Oct | 7.78 | 9.13 | 8.84 |
| 21 Wed Oct | 7.75 | 9.13 | 8.86 |
| 20 Tue Oct | 7.94 | 9.14 | 8.88 |
Biocryst Pharmaceuticals (BCRX) moving average of 200 SMA is at 8.72 and 200 EMA is at 8.78
| Date | Closing Price | 200 SMA | 200 EMA |
| 27 Tue Oct | 8.09 | 8.72 | 8.78 |
| 26 Mon Oct | 7.88 | 8.72 | 8.79 |
| 23 Fri Oct | 7.65 | 8.72 | 8.8 |
| 22 Thu Oct | 7.78 | 8.72 | 8.81 |
| 21 Wed Oct | 7.75 | 8.72 | 8.82 |
| 20 Tue Oct | 7.94 | 8.72 | 8.83 |
U S has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in U S, about 4.76% more returns!
Penumbra Inc has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Penumbra Inc, about 4.67% more returns!
Cvs Health has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Cvs Health, about 9.21% more returns!
Biocryst Pharmaceuticals has performed better than Viking Therapeutics in short term. Holding Biocryst Pharmaceuticals could be a better choice for now!
Si Bone has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Si Bone, about 16.92% more returns!
Surgery Partners has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Surgery Partners, about 71.3% more returns!
Biocryst Pharmaceuticals has performed better than Riot Blockchain in short term. Holding Biocryst Pharmaceuticals could be a better choice for now!
Regeneron Pharmaceuticals has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Regeneron Pharmaceuticals, about 10.51% more returns!
Puma Biotechnology has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Puma Biotechnology, about 12.95% more returns!
Biocryst Pharmaceuticals has performed better than Medicinova Inc in short term. Holding Biocryst Pharmaceuticals could be a better choice for now!
Kiniksa Pharmaceuticals has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Kiniksa Pharmaceuticals, about 22.44% more returns!
Biocryst Pharmaceuticals has performed better than Argenx Se in short term. Holding Biocryst Pharmaceuticals could be a better choice for now!
Biocryst Pharmaceuticals has performed better than Aquestive Therapeutics in short term. Holding Biocryst Pharmaceuticals could be a better choice for now!
Amphastar Pharmaceuticals has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Amphastar Pharmaceuticals, about 1.95% more returns!
Biocryst Pharmaceuticals has performed better than Akari Therapeutics in short term. Holding Biocryst Pharmaceuticals could be a better choice for now!
Agios Pharmaceuticals has performed better than Biocryst Pharmaceuticals in short term. You could have earned much better returns by investing in Agios Pharmaceuticals, about 17.26% more returns!
Biocryst Pharmaceuticals Technical analysis of indicators
Price action analysis of Biocryst Pharmaceuticals (BCRX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Biocryst Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Biocryst Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biocryst Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Biocryst Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biocryst Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.94 and Biocryst Pharmaceuticals BCRX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Biocryst Pharmaceuticals BCRX stock. Volume based technical analysis of Biocryst Pharmaceuticals BCRX stock is negative.
Biocryst Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock BCRX Biocryst Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And BCRX Experts View which covers a lot of information including buying and selling signals
BCRX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Biocryst Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Biocryst Pharmaceuticals (BCRX) Technical (Analysis) Reports Biocryst Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


